Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -43,597 | -88,288 | -70,698 | -40,193 | -29,672 |
| Depreciation Amortization | -819 | -46 | 1,571 | 1,308 | 1,052 |
| Accounts receivable | -18,496 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,598 | -282 | 470 | -62 | -942 |
| Other Working Capital | 78,438 | 55,702 | -1,620 | -11,798 | 54,103 |
| Other Operating Activity | 30,542 | 17,027 | 8,927 | 8,263 | 16,758 |
| Operating Cash Flow | $48,666 | $-15,887 | $-61,350 | $-42,482 | $41,299 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,546 | -4,305 | -3,985 | -5,029 | -1,030 |
| Purchase Of Investment | -494,231 | -333,228 | -147,296 | -112,350 | -220,399 |
| Sale Of Investment | 411,300 | 364,000 | 147,600 | 165,100 | 26,660 |
| Investing Cash Flow | $-90,477 | $26,467 | $-3,681 | $47,721 | $-194,769 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 80,994 | 4,749 | 59,920 | 514 | 72,965 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 104,779 |
| Financing Cash Flow | $80,994 | $4,749 | $59,920 | $514 | $177,744 |
| Beginning Cash Position | 47,594 | 32,265 | 37,376 | 31,623 | 7,035 |
| End Cash Position | 86,777 | 47,594 | 32,265 | 37,376 | 31,309 |
| Net Cash Flow | $39,183 | $15,329 | $-5,111 | $5,753 | $24,274 |
| Free Cash Flow | |||||
| Operating Cash Flow | 48,666 | -15,887 | -61,350 | -42,482 | 41,299 |
| Capital Expenditure | -7,718 | -4,305 | -3,985 | -5,029 | -1,030 |
| Free Cash Flow | 40,948 | -20,192 | -65,335 | -47,511 | 40,269 |